Unlock instant, AI-driven research and patent intelligence for your innovation.

Surface proteins of leptospira

a surface protein and bacteria technology, applied in the field of membrane associated proteins of leptospirosis bacteria, can solve the problems of high mortality rate, failure to thrive, and major problem of leptospirosis

Inactive Publication Date: 2006-10-12
FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO (FAPESP)
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This approach enables the identification and production of specific Leptospira surface proteins, facilitating the development of effective vaccines and diagnostic tools that provide long-term protection and cross-serovar immunity, addressing the limitations of existing vaccines.

Problems solved by technology

Underlying conditions associated with poverty have led to large, urban, epidemics of leptospirosis in Brazil and other countries, resulting in high mortality rates.
Leptospirosis is a major issue in agriculture as well, due to its association with livestock and domestic animals.
Among the manifestations of animal leptospirosis are spontaneous abortions, still births, infertility, failure to thrive, reduced milk production, and high fatality rates in diverse species such as cows, pigs, sheep, goats, horses and dogs.
Standard approaches to controlling this include international and national quarantines in the animal husbandry industry, with negative economic ramifications.
Clearly, there is a need to control leptospirosis; however, efforts have been hindered due to a lack of effective approaches.
Long term survival of pathogenic leptospires in soil and water, as well as the abundance of animal reservoirs support long term survival of the pathogen so eradication is not a viable option.
These vaccines do not produce long term protection against infection, and they do not confer cross protective immunity against serovars not included in the vaccines used.
The number of serovars possible, and the cost of multicomponent serovar vaccines have thwarted development in this area.
There have been difficulties in identifying surface associated Leptospira proteins using conventional biochemical and molecular biological methods.
As a result, technical difficulties have prevented meaningful results in identifying surface associated proteins; however, the emerging field of bioinformatics has placed extremely powerful and valuable tools in the hands of those involved in Leptospiral research.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Surface proteins of leptospira
  • Surface proteins of leptospira
  • Surface proteins of leptospira

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0027] A strain of Leptospira, referred to as “Fiocruz L1-30,” was used. The strain was isolated from a patient with severe leptospirosis, contracted during an epidemic in 1996. See Ko et al., Lancet 354:820-5 (1999), incorporated by reference. Leptospires were detected during dark field microscopy examination of a culture of tween-albumin media that had been inoculated with patient blood, following “Guidelines for the Control of Leptospirosis.”WHO Offset Publ. (1982) incorporated by reference. The strain was identified as Leptospira interrogans, serovar Copenhageni, via biochemical and sera typing analysis. See Ko, et al., supra, Barocchi, et al., J. Clin. Microbiol 39:191-195 (2001). A culture of the organism was then prepared in media with 10% glycerol, and stored at −70° C. Virulence capacity was determined by inoculating 28 day old weaning hamsters. Kidneys were removed from anesthetized animals, approximately 7 days after infection, macerated and were used to inoculate Tween-a...

example 2

[0032] The purified DNA described in example 1 was sequenced, using commercially available reagents, and well known methods.

[0033] Specifically, commercially available products were used to carry out Taq dye deoxy terminator cycle sequencing reactions, using M13 reverse and forward matching primers, which flanked the inserts of the clones. Reaction products were analyzed on a commercially available genetic analyzer.

[0034] There were a total of 289,963 shotgun genomic sequences. Open reading frames were obtained from these, and assembled using phred / phrap software, as described by Ewing, et al., Genome Res 8(3):186-194 (1998) incorporated by reference. The assembly yielded 2,042 contigs. The “Glimmer” program of Delcher, et al., Nucl. Acids Res 27:4636-4641 (1999), incorporated by reference, was applied to the contigs, and yielded 5826 putative open reading frames. Each of these ORFs contained at least 90 base pairs, and overlapped other ORFs by 30 base pairs, or 10% of the ORF siz...

example 3

[0047] The expression vectors resulting from the preceding examples were used to express the relevant proteins. E.coli strains BL21(DE3) or BL21SI were used under inducing conditions, including 1 mM IPTG, or 300 mM NaCl, respectively, using standard methods. Proteins were then analyzed on 10-20% SDS-PAGE gels, under denaturing conditions. Each of FIGS. 1-22 presents an SDS-PAGE pattern for the proteins.

[0048] In addition to the SDS-PAGE work, the proteins were purified, by using Ni2+ chelating sepharose. Either proteins were mixed with charged beads, or were applied onto columns in a balanced salt buffer (0.1M Tris / 0.3 M NaCl, pH 8.0). Any impurities were washed away using the same buffer, with a low concentration of imidazole (20-60 mM). Proteins of interest were then eluted, using a buffer containing imidazole at a concentration of from 0.75 to 10.M.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
total volumeaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

The invention relates to Leptospiral surface proteins, and the nucleic acid molecules which encode them. Various uses are described, including immunoprophylactic, diagnostic and therapeutic methods.

Description

RELATED APPLICATION [0001] This application is a divisional application of application Ser. No. 11 / 264,728, filed Nov. 1, 2005, which is a divisional application of application Ser. No. 10 / 889,526 filed Jul. 12, 2004, now U.S. Pat. No. 7,018,634, which is a divisional application of application Ser. No. 10 / 376,397 filed Feb. 28, 2003, now U.S. Pat. No. 6,852,322, and claims priority of application Ser. No. 60 / 360,566, filed Feb.28, 2002, incorporated by reference in their entireties.FIELD OF THE INVENTION [0002] This invention relates to membrane associated proteins of Leptospira bacteria, Leptospira Copenhageni in particular. The proteins are useful both therapeutically, as, e.g., antisera, immunoprophylactically, as vaccines, as well as diagnostically. They can be used, for example, to detect antibodies in samples taken from subjects suspected of being infected, and also to generate antibodies which can then be used to detect the proteins, epitopic portions of the proteins, as wel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K48/00C07H21/04C12P21/06A61K39/02C12N1/21C07K14/20C07K16/12A61K39/40C07K14/195C12N5/06C12N9/00C12P21/02G01N33/554G01N33/569
CPCC07K14/20A61K39/0225Y02A50/30
Inventor NASCIMENTO, ANAHO, PAULOMARTINS, ELIZABETHLEITE, LUCIANAGAMBERINI, MARCIA
Owner FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO (FAPESP)